Leadership Overview
Accupac has 4 executives leading key functions including strategy, operations, finance, and human capital.
Driven by a commitment to excellence, Accupac provides outsourced manufacturing and packaging solutions, focusing on pharmaceutical and personal care products to enhance market reach and product integrity.
Driven by a commitment to excellence, Accupac provides outsourced manufacturing and packaging solutions, focusing on pharmaceutical and personal care products to enhance market reach and product integrity.
Leadership Roles at Accupac
Edward Gotch - Chief Executive Officer
Edward Gotch, the Chief Executive Officer at Accupac, directs the overarching corporate strategy and long-term vision. Overseeing all major business units, Gotch ensures operational alignment with market demands for pharmaceutical and personal care manufacturing. This leadership role involves driving innovation in packaging solutions and expanding service offerings to meet evolving client needs. By fostering strategic partnerships, Edward Gotch strengthens Accupac's position as a premier outsourced manufacturing provider. The Chief Executive Officer's focus remains on sustainable growth and enhancing shareholder value through meticulous execution of business objectives.
Paul Alvater - President & Chief Executive Officer
Paul Alvater, the President & Chief Executive Officer at Accupac, spearheads the company's operational execution and market expansion initiatives. Alvater guides the integration of advanced manufacturing technologies to optimize production workflows for pharmaceutical and personal care products. This executive position involves direct oversight of client relations and ensuring service delivery meets stringent industry standards. By championing efficiency improvements, Paul Alvater drives profitability and reinforces Accupac's reputation for reliability. The President & Chief Executive Officer's strategic direction ensures the company maintains its competitive edge in outsourced packaging and manufacturing services.
Joseph Warchol - Chief Financial Officer
Joseph Warchol, the Chief Financial Officer at Accupac, manages all financial operations and fiscal strategy. Warchol oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health for the organization. This critical role involves optimizing capital allocation and managing financial risks associated with manufacturing and packaging services for pharmaceutical and personal care sectors. By implementing stringent financial controls, Joseph Warchol supports Accupac's growth objectives and enhances investor confidence. The Chief Financial Officer's expertise is vital in navigating market fluctuations and securing resources for strategic investments and operational enhancements.
Katherine Gillespie - Chief Human Resources Officer
Katherine Gillespie, the Chief Human Resources Officer at Accupac, leads talent acquisition, development, and organizational culture initiatives. Gillespie designs and implements HR strategies that support Accupac's mission of providing specialized manufacturing and packaging solutions. This executive function focuses on cultivating a skilled workforce capable of meeting the rigorous demands of the pharmaceutical and personal care industries. By fostering employee engagement and ensuring compliance with labor regulations, Katherine Gillespie contributes to operational stability and efficiency. The Chief Human Resources Officer's efforts are instrumental in attracting and retaining top talent, driving the company's overall success.
Explore Leadership Teams in Manufacturing
Hetero is a global pharmaceutical company founded in 1993 and headquartered in India with operations across Asia, Europe, North America, South America, Africa, and the Middle East. The company specializes in manufacturing generic pharmaceuticals and is recognized as a major producer of anti-retroviral medications for HIV/AIDS treatment. Hetero develops and manufactures a wide range of pharmaceutical products while maintaining research facilities and production centers worldwide.
Company Leadership VS
KS
CP
Madrigal Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The company's lead candidate is MGL-3196, an orally administered, small-molecule, liver-directed, thyroid hormone receptor (THR) -selective agonist, which is in Phase II clinical trials for the treatment of non-alcoholic steatohepatitis and heterozygous familial hypercholesterolemia.
Company Leadership
RF
SK
CW
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. PPS also offers development and manufacturing services for biologics including vaccines, gene therapies, and monoclonal antibodies, made possible through Piramal Pharma Limited's investment in Yapan Bio Private Limited. Our track record as a trusted service provider with experience across varied technologies we believe makes us a partner of choice for innovator and generic companies worldwide.
Company Leadership BC
SL

RM
American Regent, Inc, a Daiichi Sankyo Group Company, develops, manufactures, and supplies high quality sterile injectables for healthcare providers, clinics and hospitals across the United States and Canada. We have locations in New York, Ohio, and Pennsylvania and sales territories nationwide.
Company Leadership RT

JB
JO